The 2025 NCCRED Symposium discussed the cutting edge of research and clinical practice in methamphetamine use disorder bringing together leading researchers, clinicians, and peers.

Some key themes of the symposium included:

Early-stage treatments and approaches to methamphetamine use disorder
Trials and voices in methamphetamine use disorder research

Symposium programme

Download a PDF version below.

NCCRED 2025 Symposium Program PDF

Recordings: Innovative Pathways: Early-stage treatments and approaches to methamphetamine use disorder

Towards a Better Continuum of Care: Integrating Psychosocial and Pharmacological Interventions for Methamphetamine Use Disorder

Keynote address

Professor Didier Jutras-Aswad, Centre Hospitalier de l'Université de Montréal (CHUM) and the Université de Montréal (UdeM)

The Tina trial: the characteristics of people enrolled in a clinical trial of mirtazapine for methamphetamine use

Prof Rebecca McKetin, Professor - National Drug and Alcohol Research Centre (NDARC), UNSW

Lisdexamfetamine in the treatment of methamphetamine dependence: a randomised controlled trial (the LiMA trial)

Prof Nadine Ezard Director - NCCRED, UNSW Clinical Director - Alcohol & Drug Service, SVHS

A qualitative study of First Nations participant experiences in a randomised controlled trial of lisdexamfetamine versus placebo for the treatment of acute methamphetamine withdrawal

Dr Krista Siefried - Clinical Research Lead & Deputy Director - NCCRED, UNSW Senior Research Fellow - Alcohol & Drug Service, SVHS &

Julie Matheson - Research Officer - University of Sydney

Panel Discussion: Approaches to contingency management

Panel Chair: Adrian Tait - AOD Client and Peer Advocate - SVHS

Panel Members:

Prof Didier Jutras-Aswad - Chief of the Department of Psychiatry - Centre Hospitalier de l'Université de Montréal (CHUM) Professor - Université de Montréal (Udeм)

Maureen Steele - Consumer Engagement Coordinator - AOD Value Based Health Care Program, Centre for Alcohol and Other Drugs, NSW Ministry of Health

Angus Mason - Aboriginal Research Officer - Community Restorative Centre

Dr Suzie Hudson - Clinical Advisor - Centre for Alcohol and Other Drugs, NSW Ministry of Health

Recordings: Building the evidence base: trials and voices in methamphetamine use disorder research

Oral naltrexone and bupropion for methamphetamine use disorder: a mixed methods analysis of safety, feasibility and acceptability in a pilot clinical trial

Dr Liam Acheson - Postdoctoral fellow - NCCRED, UNSW

Ketamine assisted psychotherapy for methamphetamine use disorder: the KAPPA pilot study protocol

Dr Brendan Clifford - Senior Research Fellow & Deputy Director - NCCRED, UNSW Clinical Research Coordinator - Alcohol & Drug Service, SVHS

Psilocybin assisted psychotherapy for methamphetamine use disorder: results and considerations from the PsiMA pilot trial

Dr Elizabeth Knock - Senior Clinical Psychologist & Allied Health Lead - Alcohol & Drug Service, SVHS Clinical Research Scholar - NCCRED, UNSW

Panel Discussion: Peer partnerships in practice: redefining expertise in clinical research

Panel chair: Jess Doumany - Research Lead - Australian Injecting & Illicit Drug Users League (AIVL)